Hi All,

A concept floated around to consolidate the merits of the stocks being discussed on biotech startups to arrive at investment sentiments which might provide guidelines, but not recommendations on investments.

Gummies are responsible to take their individual decisions and benefit out of the effort put forth by KSS and team in identifying promising startups.

Happy Investing ….
Seeking everyone’s prosperity and happiness

Rating System being discussed – a sample

Stock   -  cash - trials - Science - Consistency - Management - Outside - Rating - Reward -  Trailing - Comments
                                                                Triggers                     Stop
           (0-3)   (0-4)    (1-4)     (0-4)         (0-4)       (0-3)

GILD 3 3 3 3 3 3 18(E) Med 25 % Growing
TLOG 1 1 4 2 4 2 14(G) MedHi 15 % Speculative
KPTI 2 1 3 2 3 2 12(F) MedHi 15 % Promi
sing
CLDN 1 1 3 2 3 2 12(F) MedHi 15 % Specu
lative
Benitec 1 1 3 2 3 2 12(F) Hi 15 % Binar
y
TRVN 0 1 3 2 3 2 12(F) Hi 15 % Binar
y
ARTH 0 0 4 1 3 1 9(P) Hi 5 % Binar
y

Legend:
Cash: 0 – debt; 3 – no debt, sufficient cash flow
Trials: 0 – pre, 1 – p1, 2 – p2, 3 – p3, 4 – approved (averaged out across product lines)
Science: 0 – not fully understood, not fully convincing, 4 – fully understood and convincing
Consistency: Market Performance; 0 – least; 4 – best
Management: 0 – unreliable & unpredictable; 4 – totally reliable & predictable
Triggers: 0 – no triggers or negative triggers; 3 – positive triggers or no negatives expected

Rating: Risk
E – Excellent ( >= 16) – Low
G – Good (13 – 15) – Low-Medium
F – Fair (11 – 13) – Medium
Av – Average (9-10) – Medium-High
P – Poor (< 9) – High

Trailing Stop Recommendations:
Rating Suggestion
Poor 5
Average 10
Fair 15
Good 20
Excellent 25

Comments
Promising – companies with high growth, acquisition, merger
Growing – revenue generation
Speculative – has potential
Binary – indeterministic
Sell

Suggestions welcome

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.